<SEC-DOCUMENT>0001193125-23-277996.txt : 20231220
<SEC-HEADER>0001193125-23-277996.hdr.sgml : 20231220
<ACCEPTANCE-DATETIME>20231115172149
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-23-277996
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20231115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aeglea BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001636282
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				464312787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		6176515940

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aeglea BioTherapeutics, Inc.
		DATE OF NAME CHANGE:	20150311
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g541146g97l17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;15, 2023 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>EDGAR CORRESPONDENCE </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange
Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office of Life
Sciences </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Laura Crotty and Dillon Hagius </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Aeglea BioTherapeutics, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Filed on August&nbsp;7, 2023 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">File <FONT STYLE="white-space:nowrap">No.&nbsp;333-273769</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On behalf of Aeglea
BioTherapeutics, Inc. (the &#147;<I>Company</I>&#148; or &#147;<I>Aeglea</I>&#148;), this letter responds to the comments of the staff of the Securities and Exchange Commission Division of Corporation Finance (the &#147;<I>Staff</I>&#148;) contained
in your letter, dated October&nbsp;20, 2023 (the &#147;<I>Comment Letter</I>&#148;) regarding the above-referenced Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (the &#147;<I>Amended Registration Statement</I>&#148;),
which was originally filed on Form <FONT STYLE="white-space:nowrap">S-3</FONT> on August&nbsp;7, 2023. The Staff&#146;s comments are set forth below, followed by the Company&#146;s responses following our call with Staff on November&nbsp;9, 2023.
For ease of reference, the heading and numbered paragraphs below correspond to the heading and numbered comments in the Comment Letter. The Company&#146;s responses are set forth in ordinary type beneath the Staff comment, which is set out in bold
type. References are made to the Company&#146;s Amendment No.&nbsp;1 to the Amended Registration Statement (&#147;<I>Amendment No.</I><I></I><I>&nbsp;1</I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>General </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>We note the representation in Section&nbsp;2.4 of the Agreement and Plan of Merger, filed on June&nbsp;23,
2023 as exhibit 2.1 to Aeglea&#146;s Form <FONT STYLE="white-space:nowrap">8-K,</FONT> that Spyre&#146;s holders were required to consent to the merger. We further note your Form <FONT STYLE="white-space:nowrap">S-1</FONT> seeks to registers the
resale of securities issued and issuable to Spyre&#146;s security holders as consideration for the merger. Please revise to identify all former affiliates of Spyre reselling pursuant to this Form <FONT STYLE="white-space:nowrap">S-1</FONT> as
underwriters and fix a selling price for the duration of their offering. See&nbsp;Securities Act Rule 145(c). </B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In response to the
Staff&#146;s comment, the Company has removed all former affiliates of Spyre from the selling stockholder table in Amendment No.&nbsp;1. Specifically, the Company has removed as selling stockholders Fairmount Healthcare Fund L.P., Fairmount
Healthcare Fund II L.P., Fairmount Healthcare <FONT STYLE="white-space:nowrap">Co-Invest</FONT> L.P., Paragon Therapeutics, Inc., Parapyre Holding LLC and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center"><BR>


<IMG SRC="g541146g31t80.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g541146g31o61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;15, 2023 </P> <P STYLE="font-size:16pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Spyre Advisors LLC, which were the only former affiliates of Spyre listed as selling security holders in the Registration Statement (including both shares acquired as merger consideration and
shares purchased for cash from the Company in the concurrent private placement).<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> Additionally, the Company has elected to remove Cameron Turtle, Ph.D. as a selling stockholder from the
Registration Statement. Dr.&nbsp;Turtle was not an affiliate of Spyre at the time of the merger, but is currently an officer of the Company and was a consultant of Spyre at the time of the merger. None of the remaining selling stockholders set forth
in Amendment No.&nbsp;1 were officers, directors or <FONT STYLE="white-space:nowrap">greater-than-10%</FONT> holders of Spyre capital stock at the time of the Spyre stockholder vote or as of the consummation of the merger with Aeglea. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Please revise to remove all incorporation by reference from the Form
<FONT STYLE="white-space:nowrap">S-1</FONT> and file a complete prospectus with your amendment. See General Instruction VII.D.1.b to Form <FONT STYLE="white-space:nowrap">S-1.</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In response to the Staff&#146;s comment, the Company has amended the Amended Registration Statement by removing all information previously incorporated by
reference and has filed a complete prospectus with Amendment No.&nbsp;1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Thank you for your consideration of this response. If you have any questions regarding the response set forth above, please do not hesitate to
call me at (415) <FONT STYLE="white-space:nowrap">393-8373</FONT> or Branden Berns at (415) <FONT STYLE="white-space:nowrap">393-4631.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Ryan A. Murr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Ryan A. Murr</TD></TR>
</TABLE></DIV> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Thomas Kim, Gibson, Dunn&nbsp;&amp; Crutcher LLP </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Brian Lane, Gibson, Dunn&nbsp;&amp; Crutcher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cameron Turtle, Aeglea BioTherapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Scott Burrows, Aeglea BioTherapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Heidy King-Jones, Aeglea BioTherapeutics, Inc. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For purposes of this response, we have defined &#147;affiliates&#148; of Spyre at the time of the merger as all
officers, directors and holders of at least 10% of the issued and outstanding capital stock of Spyre. As Fairmount and entities controlled by Fairmount or under common control with Fairmount owned approximately 93% of Spyre at the time of the
merger, these Fairmount-affiliated entities were in &#147;control&#148; of Spyre for purposes of affiliate status under Rule 405 under the Securities Act. No parties remaining listed as selling stockholders are controlled by Fairmount or under
common control with Fairmount. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g541146g31o61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g541146g31o61.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@               0  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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J$>GH:M6PQ;H,D^Y))_,T44-Z#2U(H8(HM2GD1 K2(I8CN<FBBBI8T?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g541146g31t80.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g541146g31t80.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0!.17AI9@  34T *@    @ ! ,!  4
M   !    /E$0  $    ! 0   %$1  0    !   2<U$2  0    !   2<P
M     8:@  "QC__; $, " 8&!P8%" <'!PD)" H,% T,"PL,&1(3#Q0=&A\>
M'1H<'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_; $,!"0D)# L,
M& T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,O_  !$( !P"8P,!(@ "$0$#$0'_Q  ?   !!0$! 0$!
M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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EGQDGEB2>ON30!+1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g541146g97l17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g541146g97l17.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MU1116!L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD_F[,%^<L JC;G/0<=\9))K?\(=:&VDLVOKXV)25(;42*$A$F<XXR< D+N)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHK(U[6'TB.T\J)9)+F;RAN#D#",V<(K$
M_=QT[T :]%<U_P )4K:I:VR&U\B2&"1KC<Y4^:6 "D)MZKQN(R2!4^B^(CJM
M_/ ZPQ!6E$29?>X20H3RH4CIG:3C(H WJ*Y#4/%]S8WWB&U^R1.]E'&; 9/[
M]V5,JWIAY$''9JLP^+[=+6WENQF6>&V98((SG?*C/@%C@\(V.G3')(H Z:BL
M&;Q39[=26)9E:QA:261X"4C(0/AAG.<$<<9Y .13I_%>FVLMRLOV@1VZR[IA
M$2CM&NYT4]V !X]CCH: -RBJ&G:M#J:7'E13QRV[[)(IDV,"5##CW# UR\7C
M6^CTJ^O+FUMY)[>%9'L8MZ7$#%@"CJ_W@,_?'!P<#I0!V]%8$GB_3HI+B-HK
MOS()EMV4Q8S*R!_+!) +!3D\X [TQ/&NC32V\<,LDOGJFQE3C<X)1#DYW''3
MU(SC- '145FZ!JC:UH-EJ3VTELUQ$LAB?J,C^7I6E0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$K,SY=-^\N>,#<HP>3SCIS+;ZW+9^!--U"9C-=36T #N"09'4?,V!PH)R3Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M38Z?$;^!+@R>1>21*C%)1%OVA68*,\'D]"/J,J;4KQY[/[5J%M9S+>VPENT
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=\J-P&,XYQ2[5]!^5%% "T444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
